[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:urinary-frequency":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":28,"states":29},"Urinary Frequency",3,2,[8,15,21],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT06789406","PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB",[],"RECRUITING","2026-08-26T02:18:14.396999Z","2026-05-05T02:43:29.534352Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT06511141","Sacral Neuromodulation for Male Overactive Bladder (MOAB)",[],"2026-08-26T02:16:20.336282Z","2026-05-05T02:43:27.836867Z",{"nct_id":22,"title":23,"phases":24,"status":25,"updated_at":26,"content_modified":27},"NCT06483217","Optimal Injection Interval for Intra-Detrusor Botulinum Toxin",[],"UNKNOWN","2026-08-03T03:47:53.324478Z","2026-05-05T02:35:31.626543Z",[],[]]